Por: RTTNews Health September 01, 2023
CRISPR Therapeutics (), a gene editing company developing gene-based medicines for serious diseases, is scheduled to participate in a fireside chat at Citi's 18th Annual Biopharma Conference on September 6.Exa-cel, formerly known as CTX001, an investigational, autologous, ex vivo CRISPR/Cas9 gene-edited therapy, being jointly developed by Vertex Pharmaceuticals Inc. (VRTX) and CRISPR Therapeutics, for severe sickle cell disease and... + full article
The New York Times USA Opinion March 04, 2023
Since James Watson and Francis Crick first described the structure of the DNA double helix, scientists have debated the potential for creating genetically modified babies. In 2018, a Chinese scientist named He Jiankui announced he had actually done it: He used a gene editing... + más
Supreme Court says it hasn’t identified person who leaked draft opinion | The Boston Globe
Supreme Court says it failed to identify who leaked draft abortion opinion that overturned Roe v. Wade | ABC News
The New York Times USA Opinion December 09, 2022
The parents of a 2-year-old girl write that their daughter “could die within the next year” because a genetic mutation is causing her heart to fail.“Time is quickly running out for me,” writes a man in his mid-30s whose DNA harbors a genetic mistake certain to destroy... + más
Justice Alito accused of being SCOTUS leaker after new report: Disgrace | Newsweek
Why would Mac Jones get a second opinion on his injury, and how common is that? | The Boston Globe
The Boston Globe USA Business December 07, 2022
A Cambridge biotech company using to develop therapies for blood cancers said that its experimental treatment for acute myeloid leukemia proved safe in the first recipient, who is currently in remission.The preliminary results, announced Wednesday morning, were a long time... + más
Boston startup Ascidian Therapeutics charts vision for therapies that ‘rewrite RNA’ | The Boston Globe
Opinion | The New York Times
ABC News USA Tech November 04, 2022
The lone volunteer in a unique study involving a gene-editing technique has died, and those behind the trial are now trying to figure out what killed him.Terry Horgan, a 27-year-old who had Duchenne muscular dystrophy, died last month, according to Cure Rare Disease, a... + más
Death in CRISPR gene therapy study sparks search for answers | Associated Press
Starting a Revolution Isn’t Enough | The Atlantic
The Boston Globe USA Business October 12, 2022
Competition is heating up among biotech startups building technologies that improve or expand upon what gene editing can do. While most of these firms are devising therapies that permanently modify DNA to treat, and potentially cure, genetic diseases, a growing number think that... + más
Tech insiders have a lot to say about the local startup scene. Most of it is good. | The Boston Globe
See the presentations that hot healthcare startups used to raise millions from top VCs | Business Insider
Ars Technica USA Science October 06, 2022
Navigate Filter by topic Settings Front page layout Site theme Comment activity Sign up or login to join the discussions! Sign up to comment and more - Oct 6, 2022 12:00 pm UTC / A 3D illustration of the HIV virus. Share this story In July, an HIV-positive man became the first... + más
HIV-positive people who have monkeypox are hospitalized more often, CDC study says | CNBC
The Atlantic USA Science September 24, 2022
CRISPR is changing the world—but it can do more.Erik Carter / The AtlanticSeptember 12, 2022Two years ago, I was working on my laptop in an airport lounge in Newark, New Jersey, when I glanced up and saw a couple walking with their two boys. The younger boy slowly made his way... + más
Teenagers on Revolution roster have provided a spark that bodes well for the future | The Boston Globe
‘I Think the Women Are Winning’ | The Atlantic
About iurex | Privacy Policy | Disclaimer |